{"protocolSection": {"identificationModule": {"nctId": "NCT00435162", "orgStudyIdInfo": {"id": "CVAL489K2303"}, "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure", "officialTitle": "A Randomized, Multicenter, Double-blind, 6 Week Study to Evaluate the Dose Response of Valsartan on Blood Pressure Reduction in Children 6 Months - 5 Years Old With Hypertension, Followed by a 2 Week Placebo Withdrawal Period."}, "statusModule": {"statusVerifiedDate": "2011-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-03"}, "primaryCompletionDateStruct": {"date": "2009-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2009-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-02-13", "studyFirstSubmitQcDate": "2007-02-13", "studyFirstPostDateStruct": {"date": "2007-02-14", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2010-12-17", "resultsFirstSubmitQcDate": "2011-04-15", "resultsFirstPostDateStruct": {"date": "2011-05-09", "type": "ESTIMATED"}, "dispFirstSubmitDate": "2010-12-17", "dispFirstSubmitQcDate": "2011-04-15", "dispFirstPostDateStruct": {"date": "2011-05-09", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2011-04-15", "lastUpdatePostDateStruct": {"date": "2011-05-09", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"oldNameTitle": "External Affairs", "oldOrganization": "Novartis Pharmaceuticals"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "The purpose of this study is to evaluate the safety and efficacy of three doses of valsartan (0.25, 1.0, and 4.0 mg/kg) on mean sitting systolic blood pressure (MSSBP) and mean sitting diastolic blood pressure (MSDBP) in 6 months - 5 year old children with hypertension (sitting systolic blood pressure \\[SSBP\\] \u2265 95th percentile )."}, "conditionsModule": {"conditions": ["Hypertension"], "keywords": ["Children", "pediatrics", "High Blood Pressure", "Hypertension", "Valsartan"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "TRIPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 74, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Low Dose", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Valsartan 0.25 mg/kg"]}, {"label": "Medium Dose", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Valsartan 1.0 mg/kg"]}, {"label": "High Dose", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Valsartan 4.0 mg/kg"]}], "interventions": [{"type": "DRUG", "name": "Valsartan 0.25 mg/kg", "description": "once daily", "armGroupLabels": ["Low Dose"]}, {"type": "DRUG", "name": "Valsartan 1.0 mg/kg", "description": "once daily", "armGroupLabels": ["Medium Dose"]}, {"type": "DRUG", "name": "Valsartan 4.0 mg/kg", "description": "once daily", "armGroupLabels": ["High Dose"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change in Mean Sitting Systolic Blood Pressure (MSSBP) From Baseline to End of Period 1 (Week 6)", "timeFrame": "baseline and week 6"}], "secondaryOutcomes": [{"measure": "Change From Baseline in Mean Sitting Diastolic Blood Pressure (MSDBP)to End of Period 1 (Week 6)", "timeFrame": "baseline and week 6"}, {"measure": "Change From End of Period 1 (Week 6) in Mean Sitting Systolic Blood Pressure (MSSBP) to End of Placebo-controlled Withdrawal Period (Week 8)", "timeFrame": "week 6 and week 8"}, {"measure": "Change From End of Period 1 (Week 6) in Mean Sitting Diastolic Blood Pressure (MSDBP) to End of Placebo-controlled Withdrawal Period (Week 8)", "timeFrame": "week 6 and week 8"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Children aged 6 months - 5 years at Visit 1, with a documented history of hypertension\n* Must be able to swallow liquid formulation\n* Must be \u2265 6 kg or \u2264 40 kg at randomization\n* Must have documented history MSSBP (mean of 3 measurements) must be \u2265 95th percentile for age, gender and height, at randomization\n* If patients enter with uncontrolled BP they can remain on background antihypertensives with an unchanged dosing regimen\n* If patients have had a solid organ transplant more than 1 year ago they must be on stable doses of immunosuppressive therapy\n* Parent(s)/guardian(s) are able to follow verbal and/or written instructions in the local language\n\nExclusion Criteria:\n\n* Patients with background ARB therapy\n* Patients demonstrating any clinically significant abnormalities or clinically noteworthy abnormal lab values (other than those relating to renal function)\n* AST/SGOT or ALT/SGPT \\> 3 times the upper limit of the reference range\n* Glomerular filtration rate \\< 30 mL/min/1.73m\u00b2\n* Serum potassium \\> upper limit of the reference range\n* MSSBP \u2265 25% above the 95th percentile\n* Patients exhibiting clinically significant ECG abnormalities\n* Patients that have coarctation of the aorta with a gradient of \u2265 30 mm Hg, or renal artery stenosis\n\nOther protocol-defined inclusion/exclusion criteria may apply", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "6 Months", "maximumAge": "5 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Novartis Pharmaceuticals", "affiliation": "Sponsor GmbH", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Sites in USA", "city": "USA", "state": "New Jersey", "country": "United States"}, {"facility": "Sites in Belgium", "city": "Belgium", "country": "Belgium"}, {"facility": "Sites in Brazil", "city": "Brazil", "country": "Brazil"}, {"facility": "Sites in France", "city": "Paris", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"facility": "Sites in Hungary", "city": "Hungary", "country": "Hungary"}, {"facility": "Sites in India", "city": "India", "country": "India"}, {"facility": "sites in Italy", "city": "Italy", "country": "Italy"}, {"facility": "Sites in Poland", "city": "Poland", "country": "Poland"}, {"facility": "Sites in South Africa", "city": "South Africa", "country": "South Africa", "geoPoint": {"lat": -31.3096, "lon": 18.357}}, {"facility": "Sites in Sweden", "city": "Sweden", "country": "Sweden"}, {"facility": "Sites in Turkey", "city": "Turkey", "country": "Turkey"}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "At period 1, participants were randomized (2:1:2) to Valsartan 0.25 mg/kg, 1.0 mg/kg or 4.0 mg/kg. At period 2, participants were randomized (1:1) to either stay on Valsartan or switch to placebo.", "groups": [{"id": "FG000", "title": "Low Dose in Both Periods", "description": "Valsartan 0.25 mg/kg in both periods"}, {"id": "FG001", "title": "Low Dose, Then Placebo", "description": "Valsartan 0.25 mg/kg, then placebo"}, {"id": "FG002", "title": "Medium Dose in Both Periods", "description": "Valsartan 1.0 mg/kg in both periods"}, {"id": "FG003", "title": "Medium Dose, Then Placebo", "description": "Valsartan 1.0 mg/kg, then placebo"}, {"id": "FG004", "title": "High Dose in Both Periods", "description": "Valsartan 1.0 mg/kg, then placebo"}, {"id": "FG005", "title": "High Dose, Then Placebo", "description": "Valsartan 4.0 mg/kg, then placebo"}], "periods": [{"title": "Period 1 (6 Weeks)", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "15"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "8"}, {"groupId": "FG004", "numSubjects": "15"}, {"groupId": "FG005", "numSubjects": "15"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "15"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "8"}, {"groupId": "FG004", "numSubjects": "15"}, {"groupId": "FG005", "numSubjects": "15"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}, {"title": "Period 2 (2 Weeks)", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "15"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "8"}, {"groupId": "FG004", "numSubjects": "15"}, {"groupId": "FG005", "numSubjects": "15"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "14"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "8"}, {"groupId": "FG004", "numSubjects": "15"}, {"groupId": "FG005", "numSubjects": "15"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Low Dose", "description": "Extemporaneous suspension of valsartan 0.25 mg/kg, taken once daily"}, {"id": "BG001", "title": "Medium Dose", "description": "Extemporaneous suspension of valsartan 1.0 mg/kg, taken once daily"}, {"id": "BG002", "title": "High Dose", "description": "Extemporaneous suspension of valsartan 4.0 mg/kg, taken once daily"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "30"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "30"}, {"groupId": "BG003", "value": "74"}]}], "measures": [{"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "3.4", "spread": "1.28"}, {"groupId": "BG001", "value": "3.2", "spread": "1.48"}, {"groupId": "BG002", "value": "3.3", "spread": "1.53"}, {"groupId": "BG003", "value": "3.3", "spread": "1.41"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "9"}, {"groupId": "BG003", "value": "26"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "21"}, {"groupId": "BG003", "value": "48"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change in Mean Sitting Systolic Blood Pressure (MSSBP) From Baseline to End of Period 1 (Week 6)", "populationDescription": "Analysis: Intention to Treat Imputation Technique: Last Observation Carried Forward (LOCF)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "baseline and week 6", "groups": [{"id": "OG000", "title": "Low Dose", "description": "Extemporaneous suspension of valsartan 0.25 mg/kg, taken once daily"}, {"id": "OG001", "title": "Medium Dose", "description": "Extemporaneous suspension of valsartan 1.0 mg/kg, taken once daily"}, {"id": "OG002", "title": "High Dose", "description": "Extemporaneous suspension of valsartan 4.0 mg/kg, taken once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "14"}, {"groupId": "OG002", "value": "30"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-8.3", "spread": "10.44"}, {"groupId": "OG001", "value": "-10.3", "spread": "9.83"}, {"groupId": "OG002", "value": "-14.4", "spread": "10.93"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001", "OG002"], "groupDescription": "Slope change across all 3 active treatment groups.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0990", "statisticalMethod": "Regression, Linear", "paramType": "Slope", "paramValue": "-1.05", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-2.31", "ciUpperLimit": "0.20"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Mean Sitting Diastolic Blood Pressure (MSDBP)to End of Period 1 (Week 6)", "populationDescription": "Analysis: Intention to Treat Imputation Technique: Last Observation Carried Forward (LOCF)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "baseline and week 6", "groups": [{"id": "OG000", "title": "Low Dose", "description": "Extemporaneous suspension of valsartan 0.25 mg/kg, taken once daily"}, {"id": "OG001", "title": "Medium Dose", "description": "Extemporaneous suspension of valsartan 1.0 mg/kg, taken once daily"}, {"id": "OG002", "title": "High Dose", "description": "Extemporaneous suspension of valsartan 4.0 mg/kg, taken once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "14"}, {"groupId": "OG002", "value": "30"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-4.7", "spread": "9.53"}, {"groupId": "OG001", "value": "-8.6", "spread": "12.43"}, {"groupId": "OG002", "value": "-6.7", "spread": "10.61"}]}]}]}, {"type": "SECONDARY", "title": "Change From End of Period 1 (Week 6) in Mean Sitting Systolic Blood Pressure (MSSBP) to End of Placebo-controlled Withdrawal Period (Week 8)", "populationDescription": "Analysis: Intention to Treat Imputation Technique: Last Observation Carried Forward (LOCF)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "week 6 and week 8", "groups": [{"id": "OG000", "title": "Valsartan", "description": "pooled across all dosage levels"}, {"id": "OG001", "title": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "38"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.6", "spread": "8.38"}, {"groupId": "OG001", "value": "4.1", "spread": "9.66"}]}]}]}, {"type": "SECONDARY", "title": "Change From End of Period 1 (Week 6) in Mean Sitting Diastolic Blood Pressure (MSDBP) to End of Placebo-controlled Withdrawal Period (Week 8)", "populationDescription": "Analysis: Intention to Treat Imputation Technique: Last Observation Carried Forward (LOCF)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "week 6 and week 8", "groups": [{"id": "OG000", "title": "Valsartan", "description": "pooled across all dosage levels"}, {"id": "OG001", "title": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "38"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.8", "spread": "8.99"}, {"groupId": "OG001", "value": "3.4", "spread": "8.74"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Period 1 (Baseline to Week 6) and Period 2 (Week 6 to Week 8)", "eventGroups": [{"id": "EG000", "title": "Low Dose in Both Periods", "description": "Valsartan 0.25 mg/kg in both periods", "seriousNumAffected": 1, "seriousNumAtRisk": 15, "otherNumAffected": 8, "otherNumAtRisk": 15}, {"id": "EG001", "title": "Low Dose, Then Placebo", "description": "Valsartan 0.25 mg/kg, then Placebo", "seriousNumAffected": 0, "seriousNumAtRisk": 15, "otherNumAffected": 10, "otherNumAtRisk": 15}, {"id": "EG002", "title": "Medium Dose in Both Periods", "description": "Valsartan 1.0 mg/kg in both periods", "seriousNumAffected": 0, "seriousNumAtRisk": 6, "otherNumAffected": 3, "otherNumAtRisk": 6}, {"id": "EG003", "title": "Medium Dose, Then Placebo", "description": "Valsartan 1.0 mg/kg, then Placebo", "seriousNumAffected": 1, "seriousNumAtRisk": 8, "otherNumAffected": 4, "otherNumAtRisk": 8}, {"id": "EG004", "title": "High Dose in Both Periods", "description": "Valsartan 4.0 mg/kg in both periods", "seriousNumAffected": 0, "seriousNumAtRisk": 15, "otherNumAffected": 9, "otherNumAtRisk": 15}, {"id": "EG005", "title": "High Dose, Then Placebo", "description": "Valsartan 4.0 mg/kg, then Placebo", "seriousNumAffected": 2, "seriousNumAtRisk": 15, "otherNumAffected": 11, "otherNumAtRisk": 15}], "seriousEvents": [{"term": "Enteritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Nephrotic syndrome", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Bronchospasm", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}], "otherEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Otorrhoea", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Aphthous stomatitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Cheilitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 2, "numAtRisk": 15}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 3, "numAtRisk": 15}]}, {"term": "Allergy to arthropod bite", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Acute tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Gastroenteritis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Impetigo", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Pharyngotonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Scarlet fever", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 2, "numAtRisk": 15}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Varicella", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Hypertriglyceridaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Asthmatic crisis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Increased upper airway secretion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Rhinorrhoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Dermatitis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Dermatitis bullous", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Dermatitis diaper", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Dry skin", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Pruritus", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Pruritus generalised", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 15}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}, {"term": "Urticaria", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 15}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 8}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 15}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 15}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial."}, "pointOfContact": {"title": "Study Director", "organization": "Novartis Pharmaceuticals", "phone": "862-778-8300"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-07-01", "removedCountries": ["Czech Republic", "Germany", "Lithuania", "Russian Federation", "Slovakia", "Switzerland", "United Kingdom"]}, "conditionBrowseModule": {"meshes": [{"id": "D000006973", "term": "Hypertension"}], "ancestors": [{"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M10024", "name": "Hypertension", "asFound": "Hypertension", "relevance": "HIGH"}, {"id": "M27583", "name": "Systolic Murmurs", "relevance": "LOW"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068756", "term": "Valsartan"}], "ancestors": [{"id": "D000000959", "term": "Antihypertensive Agents"}, {"id": "D000047228", "term": "Angiotensin II Type 1 Receptor Blockers"}, {"id": "D000057911", "term": "Angiotensin Receptor Antagonists"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M301", "name": "Valsartan", "asFound": "Extended", "relevance": "HIGH"}, {"id": "M4277", "name": "Antihypertensive Agents", "relevance": "LOW"}, {"id": "M4132", "name": "Angiotensin II", "relevance": "LOW"}, {"id": "M289354", "name": "Giapreza", "relevance": "LOW"}, {"id": "M4135", "name": "Angiotensinogen", "relevance": "LOW"}, {"id": "M25789", "name": "Angiotensin II Type 1 Receptor Blockers", "relevance": "LOW"}, {"id": "M28916", "name": "Angiotensin Receptor Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AnAg", "name": "Antihypertensive Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "VaCoAg", "name": "Vasoconstrictor Agents"}]}}, "hasResults": true}